U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07831863) titled 'A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy' on Sept. 04.
Brief Summary: To compare the efficacy and safety of 7MW3711 versus docetaxel in patients with locally advanced or metastatic squamous non-small cell lung cancer (sqNSCLC) .
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Lung Squamous Cell Carcinoma
Intervention:
DRUG: 7MW3711
Participants will receive intravenous (IV) infusion of 7MW3711 as per protocol
DRUG: Docetaxel
Participants will receive intravenous (IV) infusion of Docetaxel as per protocol
Recruitment Status: NOT_YET_RECRUITING
...